Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 03 May 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma

The latest issue of the American Journal of Gastroenterology reports on the long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma.

News image

Long-term outcomes after endoscopic resection provide important information for the treatment of esophageal carcinoma.

Dr Takeshi Yamashina and colleagues investigated the rates of survival and metastasis after endoscopic resection of esophageal carcinoma.

The team reported that from 1995 to 2010, 570 patients with esophageal carcinoma were treated by endoscopic resection.

Of these, the 402 patients with squamous cell carcinoma were included in our analysis.

The research team found that 17 patients had cancer invading into the submucosa up to 0.2 mm, and 35 patients had cancer invading into the submucosa more than 0.2 mm.

The mean follow-up time was 50 months.

The 5-year overall survival rates of patients with epithelial/lamina propria, muscularis mucosa , and submucosal cancer were 91%, 71%, and 71%, respectively.

The cumulative 5-year metastasis rates in patients with mucosal cancer were 47%
Am J Gastroenterology

The researchers identified depth of invasion and age as independent predictors of survival, with hazard ratios of 3.6 for muscularis mucosa cancer, and 3.2 for submucosal cancer compared with epithelial /lamina propria cancer, and 1.07 per year of age.

The cumulative 5-year metastasis rates in patients with epithelial/lamina propria, muscularis mucosa, submucosa up to 0.2 mm, and submucosa more than 0.2 mm cancer were 0.4%, 9%, 8%, and 36%, respectively. 

The research team found that identified depth of invasion as an independent risk factor for metastasis, with hazard ratios of 13 for muscularis mucosa , 40 for submucosa up to 0.2 mm, and 196 for submucosa more than 0.2 mm cancer compared with epithelial /lamina propria cancer.

The cumulative 5-year metastasis rates in patients with mucosal cancer with and without lymphovascular involvement were 47%, and 0.7%, respectively.

Dr Yamashina's team concludes, "The long-term risk of metastasis after endoscopic resection was mainly associated with the depth of invasion."

"This risk should be taken into account when considering the indications for endoscopic resection."

Am J Gastroenterol 2013; 108:544–551
23 April 2013

Go to top of page Email this page Email this page to a colleague

 03 May 2016 
PPIs and gut microbiota
 03 May 2016 
Vedolizumab for IBD
 03 May 2016 
Surgery vs medical therapy for GERD
 02 May 2016 
Mycophenolate mofetil as first-line treatment of autoimmune hepatitis
 02 May 2016 
Genetic variant that increase NAFLD risk
 02 May 2016 
Resection of colorectal polyps
 29 April 2016 
HCV infection in Baby Boomers with Medicare
 29 April 2016 
Simvastatins and survival in cirrhosis
 29 April 2016 
Crohn's disease associated genes
 28 April 2016 
Diarrheal diseases in children
 28 April 2016 
Birth outcomes in women with IBD receiving assisted reproduction
 28 April 2016 
Racial disparities in survival from colon cancer
 27 April 2016 
Celiac disease in adults
 27 April 2016 
Ultra-short celiac disease
 27 April 2016 
Dust mite and human GI tract
 26 April 2016 
Guidelines for nutrition therapy in hospitalized patients
 26 April 2016 
Polyp detection during colonoscopy
 26 April 2016 
IBS and microscopic colitis
 25 April 2016 
Estrogen deficiency and fibrosis risk in women with NAFLD
 25 April 2016 
Acceptance of Liver transplant center organ offers
 25 April 2016 
Abrupt interruption of beta-blockers in cirrhosis 
 22 April 2016 
Novel method to regenerate the esophagus
 22 April 2016 
Relapse after antiviral treatment in Hep B
 22 April 2016 
Microscopic colitis with NSAIDs and PPIs
 11 April 2016 
Infliximab vs adalimumab in ulcerative colitis
 11 April 2016 
H. pylori in treatment-naïve children
 11 April 2016 
Admissions times and outcomes for ERCP cholangitis
 08 April 2016 
Endoscopic treatment of Crohn's strictures
 08 April 2016 
Nutrition therapy in the hospitalized patient
 08 April 2016 
H.pylori effects on pediatric gastric mucosa
 07 April 2016 
CVD changes after TIPSS
 07 April 2016 
Transanal mesorectal resection for rectal cancer
 07 April 2016 
HBV during immunosuppressive therapies
 06 April 2016 
Adherence to colorectal cancer screening strategies
 06 April 2016 
Duodenal bulb biopsies in childhood celiac disease diagnosis
 06 April 2016 
Lymph node metastasis in early gastric cancer
 05 April 2016 
IBS in the US military
 05 April 2016 
Changes in blood flow in cirrhosis
 05 April 2016 
Colorectal cancer risk with serrated polyps
 04 April 2016 
Noninvasive diagnosis of celiac disease
 04 April 2016 
Metallic vs plastic stents for benign biliary strictures
 04 April 2016 
Adherence to quality indicators improves clinical outcomes in ascites
 01 April 2016 
Prognosis after colorectal cancer resection with peritoneal metastasis
 01 April 2016 
Colorectal cancer risk with non-malignant colonoscopy findings
 01 April 2016 
Intensive enteral nutrition and severe alcoholic hepatitis
 31 March 2016 
Anesthesia services during colonoscopy
 31 March 2016 
Management of Barrett’s esophagus
 31 March 2016 
Alcohol and glucose tolerance in NAFLD
 30 March 2016 
Depression and symptoms in IBS
 30 March 2016 
Electronic learning system for colon capsule endoscopy
 30 March 2016 
Gastric cancer screening
 29 March 2016 
Statins and survival in esophageal cancer
 29 March 2016 
Infant feeding practices and celiac disease
 25 March 2016 
Medical therapy and neoplasia regression in familial adenomatous polyposis
 25 March 2016 
Medical therapy compliance and ulcerative colitis recurrence
 25 March 2016 
Predicting outcomes of drug-induced acute liver failure
 24 March 2016 
Thrombocytopenia and multi-organ system failure in acute liver failure
 24 March 2016 
Patients with ulcerative colitis and their concerns
 24 March 2016 
Prediction of relapses in IBD
 23 March 2016 
Thiopurine therapy in IBD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us